100 mg/5 mL/bottle; 400 mg/20 mL/bottle
Darzalex (daratumumab injection) 100mg: 5mL; 400mg: 20mL
Daratumumab Injection
A public medicine summary is being prepared.
Public medicine directory
CD38 (Cluster of Differentiation 38) Inhibitors
Browse public medicine summaries, manufacturers, and approval information for CD38 (Cluster of Differentiation 38) Inhibitors.
3 medicinesPage 1 of 1
1800 mg (15 mL)/bottle
Darzalex Faspro (daratumumab and hyaluronidase-fihj) 1800mg
Daratumumab Injection (Subcutaneous)
A public medicine summary is being prepared.
100 mg (5 mL)/vial; 400 mg (20 mL)/vial
Darzalex (daratumumab injection) 100mg; 400mg
Daratumumab Injection
A public medicine summary is being prepared.